UPDATED Aug 23, 2025
Explore the Global Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ZYME | US$15.10 | 4.9% | 32.6% | US$1.1b | US$21.89 | PS9.2x | E-20.9% | n/a | ||
6936 | NT$35.90 | 2.1% | 3.0% | NT$2.6b | n/a | n/a | n/a | 4.7% | ||
A464280 | ₩10,600.00 | 0.09% | -69.5% | ₩58.6b | n/a | PE17.9x | n/a | n/a | ||
A014570 | ₩4,655.00 | 0.1% | -13.8% | ₩50.8b | n/a | PE113.5x | n/a | 3.4% | ||
MNKD | US$4.11 | 4.3% | -23.5% | US$1.3b | US$9.25 | PE38.4x | E32.2% | n/a | ||
600789 | CN¥10.36 | 0.6% | 49.1% | CN¥9.3b | n/a | PE22.9x | n/a | 1.3% | ||
2256 | HK$16.82 | 0.5% | 444.3% | HK$11.3b | HK$15.19 | PE69.2x | E-107.5% | n/a | ||
IBNSINA | ৳305.90 | 0.6% | 2.8% | ৳9.6b | ৳375.00 | PE15.1x | E19.4% | 2.1% | ||
300725 | CN¥46.21 | 0.5% | 77.0% | CN¥9.8b | CN¥47.00 | PE50.7x | E15.5% | 0.6% | ||
301331 | CN¥36.54 | 1.4% | 75.6% | CN¥3.7b | n/a | PE81.4x | n/a | 0.5% | ||
PRAX | US$48.78 | 5.2% | -3.1% | US$1.0b | US$99.67 | PS132.2x | E20.8% | n/a | ||
DYN | US$12.58 | 2.9% | -73.0% | US$1.8b | US$35.12 | PB3.1x | E14.8% | n/a | ||
RLAY | US$3.69 | 8.2% | -48.8% | US$636.2m | US$13.30 | PS76.1x | E6.1% | n/a | ||
ATLN | US$4.71 | 18.9% | -24.3% | US$274.9m | n/a | PE-2.8x | n/a | n/a | ||
XENE | US$38.84 | 1.7% | -4.7% | US$3.0b | US$54.89 | PS399.3x | E22.0% | n/a | ||
8432 | NT$48.70 | 2.7% | -14.9% | NT$1.9b | n/a | PE16.3x | n/a | 4.4% | ||
600721 | CN¥8.75 | 1.5% | 49.6% | CN¥3.4b | n/a | PE81x | n/a | n/a | ||
CUV | AU$12.93 | 7.8% | -3.3% | AU$646.6m | AU$24.42 | PE16.7x | E10.5% | 0.4% | ||
SOLARA | ₹631.60 | 0.2% | -13.4% | ₹30.4b | ₹566.00 | PE124x | E60.4% | 0% | ||
600664 | CN¥4.04 | 0.5% | 28.3% | CN¥10.2b | CN¥4.95 | PE15.3x | E17.8% | 0% | ||
RGNX | US$9.01 | 11.1% | -25.7% | US$455.1m | US$29.75 | PS2.9x | E23.5% | n/a | ||
COGT | US$12.12 | 3.0% | 19.1% | US$1.7b | US$20.09 | PB36x | E50.9% | n/a | ||
6733 | NT$40.35 | 1.0% | 6.7% | NT$5.0b | NT$33.00 | PS25.7x | n/a | n/a | ||
VREO | CA$0.99 | 5.3% | 50.0% | CA$940.3m | n/a | PS5.5x | S77.8% | n/a |